Sleep Number reported a decrease in net sales by 20% compared to the previous year, but saw high-single digit demand growth in the last two months of the quarter. The company's gross profit rate decreased due to product mix changes and sales deleverage, while operating expenses were reduced. The company is not providing financial guidance due to the continued uncertainty related to COVID-19.
Net sales were $285 million, down 20% compared with $356 million last year.
Gross profit rate of 57.2%, compared with 61.0% last year, reflecting product mix changes and sales deleverage as a result of COVID-19.
Operating expense reduction of $35 million or 17% versus prior year, reflects immediate actions taken to reduce expenses
Net loss per diluted share of $0.45, compared to net income per diluted share of $0.14 last year
The company is not providing any further financial guidance at this time due to the continued uncertainty related to COVID-19. The company expects to meet its liquidity needs from operating cash flows and its existing credit facility, while funding growth initiatives and other longer-term opportunities.
Visualization of income flow from segment revenue to net income